APOH and autoimmune polyendocrinopathy: Autoantibodies targeting domain I of β2GPI (anti-DI) are thought to be especially pathogenic, functioning as a better predictor of thrombotic risk in APS patients than either anti-β2GPI or anticardiolipin antibody levels [37,38].